☰

Chayanon Ngambenjawong - Publications

Affiliations: 
2012-2017 Bioengineering University of Washington, Seattle, Seattle, WA 
Tree Info Similar researchers PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Ngambenjawong C, Chan LW, Fleming HE, Bhatia SN. Conditional Antimicrobial Peptide Therapeutics. Acs Nano. PMID 35980829 DOI: 10.1021/acsnano.2c04162  0.677
2021 Chan LW, Hern KE, Ngambenjawong C, Lee K, Kwon EJ, Hung DT, Bhatia SN. Selective Permeabilization of Gram-Negative Bacterial Membranes Using Multivalent Peptide Constructs for Antibiotic Sensitization. Acs Infectious Diseases. PMID 33689277 DOI: 10.1021/acsinfecdis.0c00805  0.713
2018 Liu GW, Prossnitz AN, Eng DG, Cheng Y, Subrahmanyam N, Pippin JW, Lamm RJ, Ngambenjawong C, Ghandehari H, Shankland SJ, Pun SH. Glomerular disease augments kidney accumulation of synthetic anionic polymers. Biomaterials. PMID 29891232 DOI: 10.1016/J.Biomaterials.2018.06.001  0.593
2018 Ngambenjawong C, Sylvestre M, Gustafson HH, Pineda JMB, Pun SH. Reversibly-switchable, pH-dependent peptide ligand binding via 3,5-diiodotyrosine substitutions. Acs Chemical Biology. PMID 29481044 DOI: 10.1021/Acschembio.8B00171  0.657
2017 Ngambenjawong C, Pun SH. Multivalent polymers displaying M2 macrophage-targeting peptides improve target binding avidity and serum stability. Acs Biomaterials Science & Engineering. 3: 2050-2053. PMID 29430522 DOI: 10.1021/Acsbiomaterials.7B00332  0.705
2017 Ngambenjawong C, Gustafson H, Sylvestre M, Pun S. "A facile cyclization method improves peptide serum stability and confers intrinsic fluorescence. Chembiochem : a European Journal of Chemical Biology. PMID 29044914 DOI: 10.1002/Cbic.201700446  0.636
2017 Ngambenjawong C, Gustafson HH, Pun SH. Progress in tumor-associated macrophage (TAM)-targeted therapeutics. Advanced Drug Delivery Reviews. PMID 28449873 DOI: 10.1016/J.Addr.2017.04.010  0.598
2016 Ngambenjawong C, Pineda JM, Pun SH. Engineering an Affinity-Enhanced Peptide through Optimization of Cyclization Chemistry. Bioconjugate Chemistry. 27: 2854-2862. PMID 27779387 DOI: 10.1021/Acs.Bioconjchem.6B00502  0.682
2016 Ngambenjawong C, Gustafson HH, Pineda JM, Kacherovsky NA, Cieslewicz M, Pun SH. Serum Stability and Affinity Optimization of an M2 Macrophage-Targeting Peptide (M2pep). Theranostics. 6: 1403-14. PMID 27375788 DOI: 10.7150/Thno.15394  0.703
2016 Ngambenjawong C, Cieslewicz M, Schellinger JG, Pun SH. Synthesis and evaluation of multivalent M2pep peptides for targeting alternatively activated M2 macrophages. Journal of Controlled Release : Official Journal of the Controlled Release Society. 224: 103-11. PMID 26772876 DOI: 10.1016/J.Jconrel.2015.12.057  0.703
2015 Chu DS, Bocek MJ, Shi J, Ta A, Ngambenjawong C, Rostomily RC, Pun SH. Multivalent display of pendant pro-apoptotic peptides increases cytotoxic activity. Journal of Controlled Release : Official Journal of the Controlled Release Society. 205: 155-61. PMID 25596326 DOI: 10.1016/J.Jconrel.2015.01.013  0.746
Show low-probability matches.